Clinical Trials Browser

Phase 1/2 × Multiple Myeloma × TIC10 compound × Clear all

NCT02863991 2024-07-03

Oral ONC201 in Relapsed/Refractory Multiple Myeloma

Phase 1/2 Terminated

17 enrolled 10 charts

Multiple Myeloma

NCT03492138 2020-05-29

Ixazomib, ONC201, and Dexamethasone in Relapsed/Refractory Multiple Myeloma

Phase 1/2 Terminated

Multiple Myeloma, Recurrence